FZD8 and prostate cancer: In prostate cancer, deletion of Trp53 has been shown to upregulate the WNT receptor FZD8, which in turn promotes invasion and migration in prostate cancer cell lines, but also bone metastasis in a prostate cancer mouse model [164,165].